Ildong Pharmaceutical Reports 7.2 Billion KRW Operating Profit in 2Q, Down 11% YoY
[Asia Economy Reporter Minwoo Lee] Ildong Pharmaceutical announced on the 13th that it recorded provisional consolidated sales of 137.3 billion KRW and operating profit of 7.2 billion KRW for the second quarter of this year. Compared to the same period last year, sales increased by 0.6%, while operating profit decreased by 11.2%. Net profit for the period was recorded at 6.0 billion KRW, an increase of 0.5% over the same period.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
